share_log

CORRECTION: HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals (1-for-10 Reverse Stock Split) - Headline Earlier Published on 9th Aug

CORRECTION: HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals (1-for-10 Reverse Stock Split) - Headline Earlier Published on 9th Aug

更正:HC Wainwright&Co.继续为Rigel Pharmaceuticals(1比10反向股票拆分)保持买入——标题于8月9日早前发布
Benzinga ·  08/13 13:47

HC Wainwright & Co. analyst Joseph Pantginis maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy with 1-for-10 Reverse Stock Split.

HC Wainwright & Co.分析师Joseph Pantginis维持Rigel Pharmaceuticals(纳斯达克:rigel pharmaceuticals)的买入评级,同时进行1比10的股票拆分。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发